Evaluation of Prognostic Monitoring for Young Breast Cancer Patients
NCT04145986 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2019-11-18
Summary
The relationship between immune inflammation-related protein complexes in blood and recurrence or metastasis of breast cancer with completed standard treatment for young ladies will be studied.
Conditions
- Breast Cancer Female
Sponsors & Collaborators
-
Peking Union Medical College Hospital
lead OTHER
Principal Investigators
-
Shi Na · Peking Union Medical College Hospital
Eligibility
- Max Age
- 35 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-04-25
- Primary Completion
- 2020-03-31
- Completion
- 2025-03-31
Countries
- China
Study Locations
More Related Trials
-
A Multicenter, Open and Observational Real World Study on the Prognosis and Treatment in Young Women With Breast Cancer
NCT04970264 ·Status: UNKNOWN
-
Prognostic Value of Biomarkers in HR + / HER2 - Advanced Breast Cancer
NCT04683770 ·Status: UNKNOWN
-
The Association Between Age-related Peripheral Blood Components and Treatment Efficacy in Breast Cancer
NCT06718010 ·Status: RECRUITING
-
Inflammatory Blood Markers in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
NCT05468710 ·Status: UNKNOWN
-
The Association Between Plasma Metabolites and the Risk, Efficacy and Prognosis in Early Breast Cancer
NCT06698679 ·Status: RECRUITING
-
Predicting Long-Term Clinical Outcomes in Chinese Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
NCT06856616 ·Status: ACTIVE_NOT_RECRUITING
-
A Nation-wide Multicenter Clinical Epidemiologic Study of Chinese Females With Advanced Breast
NCT03047889 ·Status: UNKNOWN
-
A Multicenter Prospective Observational Cohort Based on a Breast Cancer Medical Record Database in China
NCT06591039 ·Status: RECRUITING
-
IL-6 and IL-8 Level of Blood and Pleural Effusion During Chemotherapy in Metastatic Breast Cancer
NCT01543126 ·Status: TERMINATED
-
Artificial Intelligence Analysis for Magnetic Resonance Imaging in Screening and Diagnosis of Breast Cancer
NCT05243121 ·Status: UNKNOWN
-
Construction and Validation of an Assessment Model of PCR After NAT on Breast Cancer Patients With AI Technology
NCT05441098 ·Status: UNKNOWN
-
Breast-Specific Gamma Imaging and Locally Advanced Breast Cancer Undergoing Neoadjuvant Chemotherapy
NCT02556684 ·Status: UNKNOWN
-
Sentinel Lymph Node Biopsy in Clinically Node-negative Early Breast Cancer Patients After Neoadjuvant Chemotherapy
NCT03381092 ·Status: UNKNOWN
-
A Study for Dynamic Prediction Model of Breast Cancer Bone Metastases
NCT06544668 ·Status: NOT_YET_RECRUITING
-
Characteristics and Treatment Trends of Young Breast Cancer in China
NCT05068115 ·Status: UNKNOWN
-
Gut Microbiome Components Predict Response to Neoadjuvant Therapy in HER2-positive Breast Cancer Patients : A Prospective Study
NCT05444647 ·Status: UNKNOWN
-
Dynamic Monitoring of HER2 and ctDNA Specific Mutations in Patients With Recurrent or Metastatic Breast Cancer by Digital PCR
NCT03947736 ·Status: UNKNOWN
-
Development of Multi-specific Antibodies Based on Immune Microenvironment of Breast Cancer
NCT05767931 ·Status: UNKNOWN
-
Rapid Assessment of Sentinel Lymph Node Metastasis Status Using a Pan-CK-targeting NIR-II Fluorescent Probe in Breast Cancer
NCT07154563 ·Status: RECRUITING
-
Molecular Analysis of Breast Cancer
NCT00569049 ·Status: COMPLETED
-
The Study on the Clinical Utility of Liquid Biopsy in Breast Cancer
NCT02902991 ·Status: UNKNOWN
-
Internal Mammary Lymph Nodes Irradiation in High-risk Breast Cancer After Neoadjuvant Chemotherapy
NCT06559696 ·Status: RECRUITING ·Phase: PHASE3
-
Immunomonitoring of Breast Cancer Patients During Systemic Treatment
NCT04925856 ·Status: RECRUITING ·Phase: NA
-
Recurrence Risk Evaluation by 21-gene Detection
NCT03841266 ·Status: COMPLETED
-
Using Bio Markers to Predict Disease Recurrence and Cognitive Function in High Risk Breast Ca
NCT00756132 ·Status: COMPLETED